| Product Code: ETC9959580 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Artificial Intelligence In Cancer Diagnostics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Artificial Intelligence In Cancer Diagnostics Market - Industry Life Cycle |
3.4 United States (US) Artificial Intelligence In Cancer Diagnostics Market - Porter's Five Forces |
3.5 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 United States (US) Artificial Intelligence In Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in the United States |
4.2.2 Technological advancements in artificial intelligence for cancer diagnostics |
4.2.3 Rising demand for personalized medicine and precision oncology |
4.3 Market Restraints |
4.3.1 High costs associated with implementing artificial intelligence technologies in cancer diagnostics |
4.3.2 Data privacy and security concerns related to patient information in AI systems |
4.3.3 Limited regulatory framework governing the use of AI in healthcare |
5 United States (US) Artificial Intelligence In Cancer Diagnostics Market Trends |
6 United States (US) Artificial Intelligence In Cancer Diagnostics Market, By Types |
6.1 United States (US) Artificial Intelligence In Cancer Diagnostics Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume, By Software Solutions, 2021- 2031F |
6.1.4 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume, By Hardware, 2021- 2031F |
6.1.5 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume, By Services, 2021- 2031F |
6.2 United States (US) Artificial Intelligence In Cancer Diagnostics Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.4 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.5 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.6 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume, By Brain Tumor, 2021- 2031F |
6.2.7 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Artificial Intelligence In Cancer Diagnostics Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume, By Hospital, 2021- 2031F |
6.3.3 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume, By Surgical Centers and Medical Institutes, 2021- 2031F |
6.3.4 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Artificial Intelligence In Cancer Diagnostics Market Import-Export Trade Statistics |
7.1 United States (US) Artificial Intelligence In Cancer Diagnostics Market Export to Major Countries |
7.2 United States (US) Artificial Intelligence In Cancer Diagnostics Market Imports from Major Countries |
8 United States (US) Artificial Intelligence In Cancer Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of AI-powered diagnostic tools in cancer treatment centers |
8.2 Rate of successful cancer diagnoses using AI algorithms |
8.3 Improvement in accuracy and efficiency of cancer diagnosis with AI technologies |
9 United States (US) Artificial Intelligence In Cancer Diagnostics Market - Opportunity Assessment |
9.1 United States (US) Artificial Intelligence In Cancer Diagnostics Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 United States (US) Artificial Intelligence In Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 United States (US) Artificial Intelligence In Cancer Diagnostics Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 United States (US) Artificial Intelligence In Cancer Diagnostics Market - Competitive Landscape |
10.1 United States (US) Artificial Intelligence In Cancer Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Artificial Intelligence In Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here